Loading Events

« All Events

The ADDRESS-LC Trial: Studying the Impact of Bezisterim on Brain fog and Fatigue in People with Long Covid

July 22 @ 3:00 pm - 4:00 pm PDT

In this webinar, we’ll be joined by panelists Michael Peluso, MD (Assistant Professor of Medicine, University of California, San Francisco) Ezra Spier (Creator, Long Covid Studies), Penelope Markham, PhD (Senior Vice President, BioVie) who will discuss the latest updates on Long COVID research and the ADDRESS-LC trial. The ADDRESS-LC trial was designed to assess the potential impact of bezisterim on cognitive impairment/brain fog and fatigue in individuals with Long COVID and is currently recruiting people 18-64 diagnosed with Long Covid. Attendees will learn more about the requirements for participation and how to join the trial.

In this discussion led by Solve M.E. President and CEO Emily Taylor, the panelists will also share how the lived experience of patients has informed the development and conduct of the trial and the importance of patient-researcher collaboration.

Date:
Tuesday, July 22, 2025
Time:
3:00 pm PST / 6 pm EST

Register here.

 

 

Help turn research into reality

Make a gift to Solve today

Skip to content